Muthusamy Shanmugam, Head of R&d, COO-novitium Ops: Ani Pharmaceuticals ANIP Sell · Filed 24/04/22

Trade details

Type: Insider sale
Amount: $1,095,442.53
Shares · price: 16,809 sh · $65.17 a share
Held after: 782,620 sh
Stock: Ani Pharmaceuticals ANIP
Person: Muthusamy ShanmugamHead of R&d, COO-novitium Ops
Trade date: 24/04/19
Filed: 24/04/22
Days to filing: 3 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

Ani Pharmaceuticals trades, last 26 weeks

What else happened in Ani Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/03/20~24/05/19

Muthusamy Shanmugam's recent trades

Muthusamy ShanmugamHead of R&d, COO-novitium Ops
SellAni Pharmaceuticals
Sell
Ani Pharmaceuticals
ANIP
$4.8M
52,988 sh
$4.8M
Filed 25/08/22
Traded 25/08/21
Muthusamy ShanmugamHead of R&d, COO-novitium Ops
SellAni Pharmaceuticals
Sell
Ani Pharmaceuticals
ANIP
$4.2M
47,012 sh
$4.2M
Filed 25/08/22
Traded 25/08/20
Muthusamy ShanmugamHead of R&d, COO-novitium Ops
Planned saleAni Pharmaceuticals
Planned sale
Ani Pharmaceuticals
ANIP
$4.8M
52,988 sh
$4.8M
Filed 25/08/21
Traded 25/08/21
Muthusamy ShanmugamHead of R&d, COO-novitium Ops
Planned saleAni Pharmaceuticals
Planned sale
Ani Pharmaceuticals
ANIP
$4.2M
47,012 sh
$4.2M
Filed 25/08/20
Traded 25/08/20
Muthusamy ShanmugamHead of R&d, COO-novitium Ops
SellAni Pharmaceuticals
Sell
Ani Pharmaceuticals
ANIP
$4.6M
52,990 sh
$4.6M
Filed 25/08/18
Traded 25/08/15